Neuralink IPO Date: Will Neuralink Go Public in 2026?

There is no Neuralink IPO date. As of October 2026, Neuralink has not filed a registration statement with the SEC (public or confidentially announced), has not named underwriters, and has no ticker symbol, so any site quoting a listing date or a "NLINK" price is guessing or worse. What does exist is a priced Series E from June 2025, an undisclosed follow-on investment in May 2026, and a busy secondary market that has repriced the company several times over.

This guide sets out what is confirmed, what the IPO path would look like when it starts, which signals would come first, and how readers outside the US follow Neuralink before any listing.

As of October 2026: all statuses, valuations and dates below were checked against public sources in the first week of October 2026. Private-company facts change quickly; re-check before acting on any of them.

Is Neuralink going public?

Not on any announced timetable. Neuralink has never publicly endorsed IPO plans, and Elon Musk has not given a date. The company has also not used the confidential draft registration route that Anthropic, Discord and Kraken's parent Payward announced, which is normally the first visible step for a large US listing. Under SEC rules a company can file a draft S-1 privately and announce only the fact of filing; Neuralink has made no such announcement.

The reasons it can afford to wait are straightforward. It has no commercial revenue yet, its devices are still in clinical trials, and it has been able to raise private capital at rising prices. Public markets would demand quarterly disclosure on a business whose main milestones are regulatory, which is an awkward fit for a pre-revenue medical device company.

What we actually know (October 2026)

The gap between the $9.65 billion round and the $42 billion print is the single most important number for anyone tracking a future Neuralink IPO. We break it down in Neuralink net worth and valuation, round by round.

Neuralink stock IPO date: why every "date" online is speculation

Searches for a Neuralink stock IPO date surface three kinds of pages: old 2021 to 2023 news stories, forum threads, and token trackers with no connection to the company. None of them cite a filing, because there isn't one.

A real US IPO leaves a paper trail in a fixed order:

1. Banks are hired. Usually reported by Bloomberg, Reuters or the FT before anything is filed.

2. Confidential draft S-1. The company may announce the submission under SEC Rule 135, as Anthropic did on 1 June 2026.

3. Public S-1. Must be made public at least 15 days before the roadshow. This is where revenue, losses and the share structure become visible.

4. Roadshow and price range. An amended S-1 with a range and an exchange ticker.

5. Pricing and first trade. Typically one to two weeks after the roadshow starts.

Neuralink has not reached step one in any reported way. That means the earliest realistic listing is several months after the first credible report of a filing, not a date you can circle today.

Will Neuralink go public at all?

Probably, eventually, but the case for waiting is strong. Three things would likely need to line up first:

• Regulatory progress. A pathway from trials to approved commercial use is what turns Neuralink from a research story into a revenue story. Public investors price medical devices on approvals and reimbursement.

• Capital needs. Neuralink raised about $1.3 billion in disclosed primary capital through the June 2025 round, per Forge data. Scaling surgery robotics and manufacturing costs more. If private rounds keep clearing at higher prices, the IPO can stay optional.

• A clean comparable. SpaceX's June 2026 listing showed public demand for Musk-linked companies, and secondary prices across that group rose afterwards. That sentiment helps, but it doesn't replace operating data.

The SpaceX example also shows the downside of guessing. SpaceX was described as "years away" from an IPO for a long time, then moved quickly once it decided. If Neuralink follows that pattern, the useful skill is reading the early signals, not predicting the month.

Is Neuralink publicly traded? No. Here is what that means in practice

Neuralink is not publicly traded on any exchange, and there is no Neuralink ticker. Three groups can hold or trade exposure today:

If you are new to the difference between owning a private share and holding price exposure, start with what pre-IPO means and tokenized pre-IPO stocks for beginners.

How non-US readers follow Neuralink before an IPO

Neuralink is one of the four names live on OpenStocks, as oNEURALINK. The token is economic price exposure only. It does not give ownership of Neuralink shares, voting rights, dividends or access to company information. OpenStocks is not affiliated with Neuralink, and the product is not available to US persons or anyone in the United States. It is aimed at eligible users outside the US and other prohibited jurisdictions, in places like Hong Kong, the UAE, the UK and the EU; eligibility depends on your jurisdiction, so check the Terms.

The practical advantage for IPO-watchers is visibility. The product page shows the token's implied valuation next to a reference mark valuation and the premium between them, so you can see whether the traded price is running ahead of or behind the reference. Implied valuation vs mark valuation explains how to read that gap. For the step-by-step on access, see how to invest in Neuralink pre-IPO and the token explainer oNEURALINK: price and implied valuation.

What happens to pre-IPO exposure if Neuralink lists?

An IPO changes the reference price for every private-market instrument tied to the company. Secondary shares become listed shares after any lock-up. Fund units follow the fund's terms. Tokenized exposure products follow their own published mechanics, which is why reading the product terms before a listing matters more than reading them after. We cover the general pattern using Anthropic's filing as the live example in Anthropic IPO: filing, timeline and pre-IPO exposure.

Signals to watch, in order of importance

1. Any report of bank mandates or a confidential filing. This is the only signal that starts the clock.

2. FDA milestones. Breakthrough designations and trial expansions move the story; a route to commercial approval would move it most.

3. A new priced round. A priced primary round well above $9.65 billion would close part of the gap with secondary prints and set the anchor an IPO would be priced against.

4. Tender offers. A company-run employee tender would reveal what Neuralink itself considers fair value.

5. Musk-group listings. SpaceX listed in June 2026. How it trades affects appetite for the next Musk-linked float.

Key takeaways

• There is no Neuralink IPO date, filing, underwriter or ticker as of October 2026.

• The last priced round valued Neuralink at $9.65 billion (June 2025). Secondary trades in 2026 implied $29 to $42 billion.

• A real IPO would be visible months ahead through bank mandates, a draft S-1 and a public S-1.

• Pre-IPO exposure today runs through accredited secondaries or, for eligible non-US users, tokenized price exposure such as oNEURALINK.

• Treat any site quoting a Neuralink share price as an exchange price with suspicion.

FAQ

When is the Neuralink IPO?

No date has been set. Neuralink has not announced a filing, hired underwriters publicly or applied for a ticker as of October 2026.

Will Neuralink go public in 2026?

It's very unlikely. Even if a confidential filing were announced tomorrow, SEC review, a public S-1 and a roadshow usually take several months.

What is the Neuralink stock ticker?

There isn't one. Pages showing NEUR.PVT are private-company data pages, not tradable listings. Crypto tokens using the Neuralink name are not issued by the company.

Can I buy Neuralink stock before the IPO?

Shares are only available to eligible investors through company-approved secondary sales or funds, usually with high minimums. Eligible non-US users can access price exposure (not shares) through oNEURALINK on OpenStocks.

Disclaimer

OpenStocks tokens represent economic price exposure only. They do not confer ownership, voting rights, dividends or information rights in any company. OpenStocks is not affiliated with Neuralink or any company mentioned. Not available to US persons or persons in the United States. Eligibility depends on your jurisdiction; see the Terms for the full list of prohibited jurisdictions. This article is for information only and is not investment advice. Pre-IPO exposure is high risk, including possible total loss, and liquidity is not guaranteed.